Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLC

Clinical trial NCT07754123 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07754123
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced or Metastatic NSCLC

Start date: 2026-09-17
Primary completion: 2028-08-31
Enrollment: 206

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.